Correlation Between Enliven Therapeutics and 4D Molecular
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and 4D Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and 4D Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and 4D Molecular Therapeutics, you can compare the effects of market volatilities on Enliven Therapeutics and 4D Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of 4D Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and 4D Molecular.
Diversification Opportunities for Enliven Therapeutics and 4D Molecular
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Enliven and FDMT is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and 4D Molecular Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 4D Molecular Therapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with 4D Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 4D Molecular Therapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and 4D Molecular go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and 4D Molecular
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.76 times more return on investment than 4D Molecular. However, Enliven Therapeutics is 1.32 times less risky than 4D Molecular. It trades about 0.02 of its potential returns per unit of risk. 4D Molecular Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 2,180 in Enliven Therapeutics on December 1, 2024 and sell it today you would lose (97.00) from holding Enliven Therapeutics or give up 4.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. 4D Molecular Therapeutics
Performance |
| Timeline |
| Enliven Therapeutics |
| 4D Molecular Therapeutics |
Enliven Therapeutics and 4D Molecular Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and 4D Molecular
The main advantage of trading using opposite Enliven Therapeutics and 4D Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, 4D Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 4D Molecular will offset losses from the drop in 4D Molecular's long position.| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
| 4D Molecular vs. Revolution Medicines | 4D Molecular vs. Black Diamond Therapeutics | 4D Molecular vs. Passage Bio | 4D Molecular vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |